We are thrilled to announce that Bikky, the pioneering Customer Data Platform (CDP) designed specifically for large, multi-unit restaurant brands, has successfully raised an impressive $8 million in its latest funding round. This substantial investment underscores the growing demand for innovative solutions that help restaurants harness the power of data to drive performance and enhance customer experiences. By seamlessly integrating with point-of-sale systems, online ordering platforms, payment processors, and loyalty programs, Bikky offers a uniquely comprehensive dataset that provides valuable insights into everything from menu performance to customer lifetime value. The platform not only empowers executives and marketing teams alike but also allows restaurants to make informed, strategic decisions that contribute positively to their bottom lines. Founded on the belief that restaurants should have access to the same robust data capabilities as the world’s largest enterprises, Bikky has already established itself as a trusted partner for thousands of restaurant locations across the U.S., including notable brands such as Bojangles, MOD Pizza, Dave’s Hot Chicken, and Long John Silver’s. With this latest funding, totaling over $15 million to date, Bikky is poised to accelerate its growth and continue enhancing its offerings, ensuring that even more restaurant brands can leverage data for success in the competitive food service landscape. The future of restaurant analytics is bright, and Bikky is leading the charge!
Bikky Secures $8 Million in Series A Funding to Revolutionize Restaurant Data Analytics
Get the full Bikky company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Anveshan
We are a food-tech startup aiming to provide high quality deeply traceable food products. We leverage technologies based on image processing, spectroscopy, blockchain and IOT to provide the best quality food products made traditionally.
$12.7M Series b
today
Caseway
We are the only enterprise AI form platform that replaces internal R&D and manual workflows by building and maintaining fully integrated automation systems, aligned to your data, your processes, and your long-term success. For document-intensive, compliance-driven organizations in regulated industries like insurance, education, finance, healthcare, and government Compelling reason to buy: Who need AI and automation tailored to their unique forms, workflows, and security environment, without having to shoulder R&D risk or manage AI development internally Product category: Our product is an enterprise document form platform Key benefit: That delivers a fully integrated, continuously improving automation system, built and maintained by experts, without upfront AI build costs Key differentiation: Our product is custom-built for each client’s systems and documents, fully integrated and continuously improved through a long-term partnership model, we maintain, debug, adapt, and align incentives to make it work in the real world.
$1.5M Pre-seed
today
Kubera Health
Kubera’s mission is to power a payment ecosystem where contracts are honored, care is rewarded, and waste is eliminated. We deliver contract and payment intelligence that unifies policies, terms, and claims data into one trusted platform — helping healthcare organizations and their partners build fairer contracts, ensure payments flow as intended, and align incentives across the care ecosystem. As healthcare shifts toward new reimbursement models and risk-sharing arrangements, Kubera is building the payment-intelligence backbone that enables multiple parties to adapt faster, protect margins, and dedicate more resources to patient care.
$6.5M Seed
today
Psilera
Psilera is a biotechnology company founded by scientists dedicated to finding better therapeutics for neurological conditions like dementia, addiction, and mental health disorders. Since 2019, Psilera has been focused on early-stage drug discovery & development with a dynamic team of experts in synthetic chemistry, pharmacology, clinical development, and business development.
$8.8M Seed
today
Abstract
Abstract is a venture capital firm based in San Francisco with $1.5 billion in assets under management. We are sector-agnostic, focused on seed and early stage founders. Our reputation among founders is built on fierce loyalty, unparalleled connections, and a relentless drive to help them win.
$59.0M Series a
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Abstract United States | Series a | $59.0M | today |
| 2 |  Pacifico Biolabs | Series a | $7.6M | today |
| 3 |  Secretome Therapeutics United States | Series a | $30.0M | today |
| 4 |  Solstice United States | Series a | $21.0M | today |
| 5 |  Geordie AI United Kingdom | Series a | $30.0M | today |